---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-283662"
form_type: "8-K"
ticker: "CTKB"
cik: "0001831915"
company_name: "Cytek Biosciences, Inc."
filed_at: "2023-11-28T23:59:59+00:00"
generated_at: "2026-06-07T21:09:37.552293+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Cytek Biosciences posts updated corporate presentation, no material new info disclosed

## Summary
- Filing references updated corporate presentation made available on company website.
- Presentation slide lists CEO Dr. Wenbin Jiang, CFO Patrik Jeanmonod, and IR Paul Goodson.
- No specific financial figures, guidance changes, or operational updates are provided in the filing or exhibit.
- The 8-K furnishes the presentation under Regulation FD; content not incorporated by reference.

## SEC filing metadata
- accession: 0001193125-23-283662
- form_type: 8-K
- ticker: CTKB
- cik: 0001831915
- company_name: Cytek Biosciences, Inc.
- filed_at: 2023-11-28T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831915/000119312523283662/0001193125-23-283662-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831915/000119312523283662/d614953d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-283662
- JSON: https://secwatch.observer/filing/0001193125-23-283662.json
- Plain text: https://secwatch.observer/filing/0001193125-23-283662.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.